Literature DB >> 25339807

Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.

Giuseppe Paradies1, Valeria Paradies1, Francesca M Ruggiero1, Giuseppe Petrosillo1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is today considered the most common form of chronic liver disease, affecting a high proportion of the population worldwide. NAFLD encompasses a large spectrum of liver damage, ranging from simple steatosis to steatohepatitis, advanced fibrosis and cirrhosis. Obesity, hyperglycemia, type 2 diabetes and hypertriglyceridemia are the most important risk factors. The pathogenesis of NAFLD and its progression to fibrosis and chronic liver disease is still unknown. Accumulating evidence indicates that mitochondrial dysfunction plays a key role in the physiopathology of NAFLD, although the mechanisms underlying this dysfunction are still unclear. Oxidative stress is considered an important factor in producing lethal hepatocyte injury associated with NAFLD. Mitochondrial respiratory chain is the main subcellular source of reactive oxygen species (ROS), which may damage mitochondrial proteins, lipids and mitochondrial DNA. Cardiolipin, a phospholipid located at the level of the inner mitochondrial membrane, plays an important role in several reactions and processes involved in mitochondrial bioenergetics as well as in mitochondrial dependent steps of apoptosis. This phospholipid is particularly susceptible to ROS attack. Cardiolipin peroxidation has been associated with mitochondrial dysfunction in multiple tissues in several physiopathological conditions, including NAFLD. In this review, we focus on the potential roles played by oxidative stress and cardiolipin alterations in mitochondrial dysfunction associated with NAFLD.

Entities:  

Keywords:  Antioxidants; Cardiolipin; Mitochondrial bioenergetics; Nonalcoholic fatty liver disease; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25339807      PMCID: PMC4202349          DOI: 10.3748/wjg.v20.i39.14205

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  143 in total

1.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Schlauch; Timothy L Born; Hazem Elariny; Francesco Gorreta; Amy VanMeter; Abraham Younoszai; Janus P Ong; Zachary Goodman; Vikas Chandhoke
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 2.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

3.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases.

Authors:  M W Cleeter; J M Cooper; V M Darley-Usmar; S Moncada; A H Schapira
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

4.  Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria.

Authors:  K Hensley; Y Kotake; H Sang; Q N Pye; G L Wallis; L M Kolker; T Tabatabaie; C A Stewart; Y Konishi; D Nakae; R A Floyd
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

5.  Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

Authors:  Jörn M Schattenberg; Yongjun Wang; Rajat Singh; Raina M Rigoli; Mark J Czaja
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

6.  Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles.

Authors:  G Paradies; G Petrosillo; M Pistolese; F M Ruggiero
Journal:  Mitochondrion       Date:  2001-08       Impact factor: 4.160

7.  Nitric oxide synthase activity in mitochondria.

Authors:  P Ghafourifar; C Richter
Journal:  FEBS Lett       Date:  1997-12-01       Impact factor: 4.124

8.  Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression.

Authors:  João S Teodoro; Anabela P Rolo; Filipe V Duarte; Anabela M Simões; Carlos M Palmeira
Journal:  Mitochondrion       Date:  2008-08-15       Impact factor: 4.160

Review 9.  ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function.

Authors:  Jingbo Pi; Qiang Zhang; Jingqi Fu; Courtney G Woods; Yongyong Hou; Barbara E Corkey; Sheila Collins; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-06       Impact factor: 4.219

Review 10.  The role of cardiolipin in the structural organization of mitochondrial membranes.

Authors:  Michael Schlame; Mindong Ren
Journal:  Biochim Biophys Acta       Date:  2009-05-04
View more
  116 in total

1.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

Review 2.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

3.  Pediatric Fatty Liver Disease.

Authors:  Ajay Jain
Journal:  Mo Med       Date:  2019 Mar-Apr

4.  Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulum.

Authors:  Marcus Trentzsch; Eugene Nyamugenda; Tiffany K Miles; Haven Griffin; Susan Russell; Brian Koss; Kimberly A Cooney; Kevin D Phelan; Alan J Tackett; Srividhya Iyer; Gunnar Boysen; Giulia Baldini
Journal:  Cell Death Discov       Date:  2020-02-18

5.  Impact of 17β-estradiol on complex I kinetics and H2O2 production in liver and skeletal muscle mitochondria.

Authors:  Maria J Torres; Terence E Ryan; Chien-Te Lin; Tonya N Zeczycki; P Darrell Neufer
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

Review 6.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

7.  Effect of endoplasmic reticulum stress inhibition on hyperoxaluria-induced oxidative stress: influence on cellular ROS sources.

Authors:  Rishi Bhardwaj; Chanderdeep Tandon; Devinder K Dhawan; Tanzeer Kaur
Journal:  World J Urol       Date:  2017-08-24       Impact factor: 4.226

Review 8.  Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases.

Authors:  Juan Li; Tongxin Wang; Jun Xia; Weilei Yao; Feiruo Huang
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

9.  Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.

Authors:  Alexandra Feldman; Sebastian K Eder; Thomas K Felder; Lyudmyla Kedenko; Bernhard Paulweber; Andreas Stadlmayr; Ursula Huber-Schönauer; David Niederseer; Felix Stickel; Simon Auer; Elisabeth Haschke-Becher; Wolfgang Patsch; Christian Datz; Elmar Aigner
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

10.  Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction.

Authors:  Long Wang; Yisong Lv; Huixiang Yao; Li Yin; Jianhui Shang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.